About INBRE with researchers in the background

INBRE Administration

Dr. R. Scott SevilleRobert "Scott" Seville, Ph.D.

Professor and Chair, Department of  Zoology and Physiology; Director, NIH IDeA Wyoming INBRE; Assoc. Director, NIH IDeA Mountain West CTR-IN Pilot Grant Program; University of Wyoming- Laramie, 1000 E. University, BS 428B and HH 234, Laramie, WY 82071; University of Wyoming- Casper, 125 College Drive, UU 438, Casper, WY 82601; Wyoming INBRE Ph#: 307-766-3333, Cell#: 307-277-3106, FAX#: 307-268-2416, sseville@uwyo.edu


Nic Blouin, Ph.D.
INBRE Bioinformatics Core Director, Research Scientist
Animal Science/Molecular Biology Complex 230

Office: (307) 766-3527; Lab: (307) 766-3518



David Fay, Ph.D.David Fay, Ph.D.
Developmental Research Projects Program Core Director
Professor of Molecular Biology
Office: (307) 766-4961; Lab: (307) 766-4962

INBRE External Advisory Committee

The External Advisory Committee (EAC)  consists of six prominent scientists. Responsibilities of this committee include preparation and submission of written critiques of scientific progress of the Wyoming INBRE, as well as progress and activities of each of the three mandatory cores (Administrative, Bioinformatics, and Outreach) to the PI and VP of Research & Economic Development. As in the past this committee will continue to have major input into programmatic issues and assessment/evaluation. In addition, the EAC will review and approve candidates for additional (or replacement) projects, mentors, and investigators as required before such requests are forwarded to NCRR for administrative confirmation and approval. The EAC will meet at least twice per year. Wyoming INBRE accomplishes the stated goals of the program.

Current EAC Members

Dr. John Sladek is the current Chair of the INBRE EAC. He is a Professor in the Program in Neurobiology, Department of Pediatrics, at the University of Colorado School of Medicine in Denver, CO. His laboratory has been at the forefront of research for therapeutic approaches for neurological disorders such as Parkinson's disease and more recently, Down syndrome. Much of their earlier work detailed the precise chemical neuroanatomy of the mammalian brain including key systems in the non-human primate. His laboratory also developed histochemical approaches for the simultaneous localization of monoamine and peptide neurons and stUdied their relationship during neural development and aging. His research has been continuously funded through extramural resources since 1971 including a number of NIH grants and 3 current ROl awards. He has held several editorial positions including serving as the Editor- in-Chief for Experimental Neurology, Editor for Cell Tissue and Research, and Section Editor for Cell Transplantation. Dr. Sladek has also held a number of administrative positions including Chair of the Department of Neuroscience at The Chicago Medical School, Vice Chancellor for Research at the UC at Denver Health Sciences Center, and President and CEO at California Lutheran University.

Dr. Carolyn Bohach is a University Distinguished Professor at the University of Idaho, has served as the Idaho INBRE Director since 2006 and, before that, as the Idaho INBRE Associate Director from 2002 to 2006. Her BS and PhD are in microbiology from the University of Illinois and the University of Minnesota, respectively; and she trained as a post-doctoral fellow at Harvard Medical School in microbiology and molecular genetics. She is an established research scientist with a history of continuous NIH funding since 1993 through R01/R01-like grants and contracts. She has collaborated with and mentored numerous junior researchers, post-doctoral fellows, graduate students, and undergraduates. Her background, coupled with her knowledge of the challenges and opportunities unique among the Western IDeA states, will facilitate the realization of the Wyoming INBRE goals to improve research infrastructure, mentor early-stage investigators, provide biomedical research experiences to undergraduate students, and improve the scientific knowledge of the workforce.  

Dr. Robin Dowell is an Associate Professor of Molecular, Cellular and Developmental Biology and Computer Science at University of Colorado Boulder. Dr Dowell is a Boettcher Investigator, Kavli Fellow, Sloan Fellow and a Linda Crnic Investigator. Dr. Dowell brings expertise in bioinformatics, computational biology, machine learning and genomics.  Her lab uses computational biology and molecular genetics to decipher transcription regulation and the activity of transcription factors. Work in her lab is funded by both NSF ABI and NIH R01 awards.  Dr Dowell is co-founder of the Boulder biotech startup Arpeggio Biosciences, who identifies mechanisms of action of drugs using RNA profiling technology.   Dr. Dowell has developed interdisciplinary training programs in computational biology, data science, and quantitative biology at CU Boulder. 

Dr. Chuck Henry is a Department Chair and Professor of Chemistry at Colorado State University.  He also holds appointments in Chemical & Biological Engineering and Biomedical Engineering. Prior to joining the Chemistry Department at Colorado State University in 2002, he was an Assistant Professor at Mississippi State University. Dr. Henry’s research interests lie in the general fields of chemical separations and lab-on-a-chip devices and he is specifically interested in the development of microfluidic devices for rapid diagnostics in biomedical application and point-of-measurement analyses for environmental samples. With the addition of the new thematic research focus “Technologies for Chronic Disease Research and Therapeutics” Dr. Henry’s membership on the EAC will provide the expertise and experience needed to foster program development and junior scientists in this new research area.

Dr. Taiowa Montgomery is a Boettcher Investigator and an Associate Professor of Biology at Colorado State University. He received his PhD from Oregon State University and afterward he was a Damon Runyon fellow at Harvard Medical School and Massachusetts General Hospital. Dr. Montgomery’s laboratory explores the roles of small regulatory RNAs in controlling gene expression from one generation to the next. His research is supported by a MIRA award from the NIH. He has experience developing and instructing courses in genomics and computational biology. He serves on the curriculum committee for the Professional Science Master’s Degree in Biological Data Analytics at CSU and previously served as Associate Director for the Cell and Molecular Biology Graduate Program at CSU. He has also served on several scientific review panels for NIH training grants. As part of his community outreach efforts, he co-developed and co-instructs an annual computational biology and genomics workshop in Mexico. Dr. Montgomery brings expertise in research, education and training in genetics, genomics and bioinformatics across all different skill levels.

Dr. Tin Tin Su is a Professor of Molecular, Cellular and Developmental Biology at University of Colorado Boulder. Her laboratory studies how cells and tissues recover and regenerate after radiation damage, using Drosophila and human cancer models. Work in the Su lab is currently funded by an NIH R35 MIRA award. Dr. Su is a co-founder and the CSO of a Boulder biotech startup that is identifying and developing novel radiation modulators for cancer. Dr. Su has chaired three NIH study sections and is a standing member of the NIH CSRS study section. She is serving as the Graduate Program Director in her home department and is one of two Program Leaders for the Molecular and Cellular Biology Program of the University of Colorado Cancer Center. Dr. Su brings expertise in research and teaching at both graduate and undergraduate levels, as well as her experience as the parent of two Colorado community college students who went on to earn four-year and graduate degrees.